FDA Inspection 888954 — Lundbeck Pharmaceuticals LLC

Lundbeck Pharmaceuticals LLC — FEI 3004100593

The FDA completed an inspection of Lundbeck Pharmaceuticals LLC on Aug 1, 2014 in Deerfield, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 1, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Deerfield, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures